GMFB
Glia maturation factor beta
Also known as: GMF, GMFB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P60983
- Gene
- GMFB
- Ensembl
- ENSG00000197045
- Chromosome
- 14
- Canonical length
- 142 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
Predicted to enable Arp2/3 complex binding activity. Predicted to be involved in actin filament debranching and negative regulation of Arp2/3 complex-mediated actin nucleation. Predicted to act upstream of or within learning and locomotory behavior. Predicted to be active in cortical actin cytoskeleton. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
142 residues, UniProt reviewed canonical sequence.
>P60983|GMFB
1 MSESLVVCDV AEDLVEKLRK FRFRKETNNA AIIMKIDKDK RLVVLDEELE GISPDELKDE
61 LPERQPRFIV YSYKYQHDDG RVSYPLCFIF SSPVGCKPEQ QMMYAGSKNK LVQTAELTKV
121 FEIRNTEDLT EEWLREKLGF FHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GMFB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 98 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 98 nTPM
- midbrain: 64 nTPM
- cerebral cortex: 63 nTPM
- amygdala: 58 nTPM
- hippocampal formation: 56 nTPM
- hypothalamus: 49 nTPM
Single-cell type
- extravillous trophoblasts: 118 nCPM
- esophageal apical cells: 79 nCPM
- colonocytes: 65 nCPM
- syncytiotrophoblasts: 63 nCPM
- migrating cytotrophoblasts: 63 nCPM
- schwann cells: 60 nCPM
Immune cell
- neutrophil: 16 nTPM
- non-classical monocyte: 14 nTPM
- intermediate monocyte: 13 nTPM
- myeloid DC: 13 nTPM
- classical monocyte: 10 nTPM
- eosinophil: 9.1 nTPM
Brain region
- spinal cord: 121 nTPM
- white matter: 119 nTPM
- hypothalamus: 103 nTPM
- medulla oblongata: 97 nTPM
- thalamus: 96 nTPM
- basal ganglia: 85 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.31
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament debranching
- learning
- locomotory behavior
- negative regulation of Arp2/3 complex-mediated actin nucleation
- nervous system development
- protein phosphorylation
Molecular functions
- actin binding
- Arp2/3 complex binding
- enzyme activator activity
- growth factor activity
- protein kinase inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GMFB as an antibody target. Whether an autoantibody or antibody against GMFB could matter depends on whether native GMFB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GMFB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GMFB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...